Cardiology

Scientists link certain gut bacteria to lower heart disease risk

Changes in the gut microbiome have been implicated in a range of diseases including type 2 diabetes, obesity, and inflammatory bowel disease. Now, a team of researchers at the Broad Institute of MIT and Harvard along with ...

Medications

Aspirin cuts liver fat in clinical trial

The most common chronic liver disease—metabolic dysfunction–associated steatotic liver disease (MASLD)—is characterized by an increased buildup of fat in the liver due to factors such as obesity and type 2 diabetes.

page 1 from 7